Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The triumvirate of beta-cell regeneration: Solutions and bottlenecks to curing diabetes.
Int. J. Dev. Biol. 62, 453-464 (2018)
On 11 January 1922 insulin injection was used for the first time in the treatment of diabetes. Even today, daily insulin injections are the life-saving treatment for patients with Type 1 diabetes and advanced Type 2 diabetes. However, insulin injections often fail to achieve full glucose control, which in the long-term leads to multiple complications and mortality. Beta-cells, the natural producers and secretors of insulin, remain the gold-standard in regulating blood glucose levels. In this review, we focus on three strategies aiming at counteracting beta-cell loss in order to gain insulin independence: replacement, replication and protection. The three approaches, together termed as the triumvirate of beta-cell regeneration, may constitute the basis for a future cure for diabetes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
1.579
0.657
3
4
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Reprogramming ; Regeneration ; Protection ; Diabetes; Insulin-producing Cells; In-vivo; Centroacinar Cells; Secreting Cells; Stem-cells; Mass; Endocrine; Islets; Liver; Differentiation
Sprache
englisch
Veröffentlichungsjahr
2018
HGF-Berichtsjahr
2018
ISSN (print) / ISBN
0214-6282
e-ISSN
1696-3547
Zeitschrift
International Journal of Developmental Biology
Quellenangaben
Band: 62,
Heft: 6-8,
Seiten: 453-464
Verlag
University of the Basque Country Press (UBC Press)
Verlagsort
Po Box 1397, Bilbao, Bizkaia E-48080, Spain
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Pancreatic Islet Research (IPI)
POF Topic(s)
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502600-010
WOS ID
WOS:000451691600013
Erfassungsdatum
2018-12-20